Tilidine
NERVOUS SYSTEM
Also known as: tilidate, tilidine HCl, tilidine hydrochloride, tilidine hydrochloride hemihydrate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Tilidine is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1970. DrugCentral lists 1 molecular target, including OPRM1. Recorded indications include Pain.
- Molecular targets: OPRM1 (1 listed in DrugCentral).
- Indications: Pain.
- ATC code: N02AX01 (Other opioids).
- Molecular formula: C17H23NO2; molecular weight 273.38 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Pain
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Mu-type opioid receptor | OPRM1 | agonist | EC50 5.10 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1970-01-01 | YEAR INTRODUCED | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N02AX01 | NERVOUS SYSTEM › ANALGESICS › OPIOIDS › Other opioids |
N02AX51 | NERVOUS SYSTEM › ANALGESICS › OPIOIDS › Other opioids |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Brain oedema | 224.5 |
| Pulmonary oedema | 137.0 |
| Toxicity to various agents | 112.9 |
| Respiratory depression | 84.7 |
| Hepatitis E antibody positive | 82.2 |
| Hepatitis E virus test positive | 80.2 |
| Suspected transmission of an infectious agent via product | 64.4 |
| Psychiatric decompensation | 46.6 |
| Hydrocholecystis | 40.7 |
| VACTERL syndrome | 40.6 |
| Poisoning | 40.0 |
| Substance abuse | 38.8 |
Chemical structure
| Molecular formula | C17H23NO2 |
|---|---|
| Molecular weight | 273.38 g/mol |
| CAS number | — |
| InChIKey | WDEFBBTXULIOBB-UHFFFAOYSA-N |
| PubChem CID | 30131 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Tilidine used for?
DrugCentral lists the following indications for Tilidine: Pain.
How does Tilidine work?
Its molecular targets in DrugCentral include OPRM1 (agonist).
When was Tilidine first approved?
Tilidine was first approved by the YEAR INTRODUCED in 1970.
What is the chemical formula of Tilidine?
Tilidine has the molecular formula C17H23NO2 and a molecular weight of 273.38 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2663 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2218854 — compound record and bioactivity
- PubChem CID 30131 — chemical identifiers
- DrugBank DB13787 — drug record
- FDA UNII GY33N31E9Y — substance identity
- UniProt P35372 (OPRM1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.